Treatment Horizons

Chronic Relief? A self-injectable monoclonal antibody vies to become a monotherapy by Chael Needle Anti-HIV agents currently being researched these days seem split between (1) improving regimens...

AIDS Healthcare Foundation Trains a Research Lens on Probiotics by Chael Needle "Probiotics” has become a new buzz word in the dairy aisle—at least two brands...

Treatment Horizons by Chael Needle Hill & Mountain? Weakened federal support of HIV/AIDS services puts our health at risk President Obama’s fiscal year 2014 budget plan includes...

On July 26, 2017, the Centers for Disease Control and Prevention released new data on the nation’s progress in HIV testing and treatment, showing...

LifeGuide Therapeutic Vaccines May Change the Treatment Landscape for the Better by Jeannie Gibbs Clinical development of HIV therapeutic vaccine candidate, Vacc-4x, will continue after further...

When it comes to Effective HIV reform, don’t throw the baby out with the bathwater by Mariel Selbovitz, MPH, and Leslie G Selbovitz, MD LifeGuide Extensive progress in...

The 6th IAS Pathogenesis Conference doesn't really end after the closing session by David Miller In 1987 I attended my first AIDS conference, beginning twenty-four years...

Treatment Horizons by Chael Needle Surpassing Expectations ViiV Healthcare introduces its first FDA-approved agent ViiV Healthcare is exclusively devoted to the treatment of HIV disease, and the...

Express Lane A Vaccine Candidate Seeks to Prevent—Not Just Control—HIV Infection by Chael Needle Preventative HIV vaccine research has taken another step. The candidate, a granulocyte-macrophage colony stimulating factor...

Undetectable is a worthy goal, no doubt about it. A suppressed viral load very often means the individual living with HIV is adherent to...